Abstract 1829P
Background
To investigate the nutritional status of hospitalized patients with common malignant tumor in a cancer hospital of Southwest China.
Methods
From April 2017 to May 2021, we enrolled 891 patients with cancer hospitalized for treatment in Chongqing university Cancer Hospital. These patients were diagnosed with one of the following 16 different types of malignant tumors: lung cancer, gastric cancer, liver cancer, colorectal cancer, breast cancer, esophageal cancer, cervical cancer, endometrial cancer, nasopharyngeal carcinoma, malignant lymphoma, leukemia, pancreatic cancer, ovarian cancer, prostate cancer, bladder cancer and brain tumor. Patient-generated subjective global assessment (PG-SGA), anthropometric measurements, and laboratory examination were used to evaluate the nutritional risk or nutritional status.Cancer pain status were assessed with the Numerical Rating Scale (NRS). We also investigated the nutritional therapy of these cancer patients.
Results
According to the PG-SGA score, 48.7% (434/891) of the cancer patients were severe malnutrition (PG-SGA≥9), 31.2% (312/891) were moderate malnutrition (8≥PG-SGA≥4), 14.7% (131/891) were mild malnutrition (PG-SGA 2∼3), and only 5.4% (48/891) patients were no malnutrition (PG-SGA 0∼1). The rate of malnutrition for gastrointestinal cancer patients is higher than Nongastrointestinal cancer patients (67.3% vs. 44.6%, χ2=31.48, P <0.001). Multiple linear regression analysis, PG-SGA scores and body mass index (P<0.001), serum total protein(P<0.001), hemoglobin serum(P<0.001), albumin (P<0.001), prealbumin (P<0.001), calf circumference (left side, P=0.001) were correlated. Age(≥65 years), albumin(<40g/L), prealbumin (<150mg/L) and cancer pain (NRS≥4) are the risk factors of severe malnutrition. However, only 26.8% (200/746) of all the moderately and severely malnourished patients received nutritional therapy.
Conclusions
94.6% of the common malignant tumor patients enrolled in the present study were malnutrition. Nutritional therapy of malignant tumor patients with malnutrition is very low.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1885P - Serum ATG5 protein may determine chemotherapy-related cognitive dysfunction in older patients with cancer
Presenter: Ozgur Tanriverdi
Session: Poster session 12
1886P - Expectations and priorities of older patients with cancer: The PRIORITY multicenter cohort study
Presenter: Thomas Grellety
Session: Poster session 12
1887P - Effect of logotherapy on chronic sorrow, dignity, and meaning in life of palliative care patients
Presenter: Yasemin Eskigulek
Session: Poster session 12
1888P - PalliScore: Validation of a rapid scoring system for enhancing decision-making in the Emergency Department for cancer patients in palliative care
Presenter: Rafael Carmo
Session: Poster session 12
1889P - Addressing unmet needs in the management of persistent severe cancer pain: European expert recommendations
Presenter: Mario di Palma
Session: Poster session 12
1890P - End-of-Life (EOL) systemic anticancer treatment (SACT) and health services use before and during the COVID-19 pandemic
Presenter: Javaid Iqbal
Session: Poster session 12
1891P - The effects of glucagon-like peptide 1 agonists on immune checkpoint inhibitor-associated cardiotoxicity
Presenter: Cho Han Chiang
Session: Poster session 12
1892P - Glucagon-like peptide 1 agonists and anthracycline-associated cardiotoxicity in hematologic malignancies
Presenter: Cho Hung Chiang
Session: Poster session 12
1893P - Incidence of myocardial ischemia during treatment with capecitabine: Assessment with Holter recording and cardiac biomarkers
Presenter: Anne Dyhl-Polk
Session: Poster session 12
1894P - Pulmonary function test (PFT) and circulating biomarkers in immune-related pneumonitis (irP) in advanced non-small cell lung cancer (aNSCLC): A real-world multidisciplinary experience
Presenter: Loc Carlo Bao
Session: Poster session 12